Additional Details
-
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)Middletown NJ. 07748View Details -
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)Basking Ridge NJ. 07920View Details -
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)Commack NY. 11725View Details -
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
UCLA Health Westwood Medical PlazaWestwood CA. 90095View Details -
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Tampa General HospitalTampa FL. 33606View Details -
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
St. Vincent Cardiovascular Research InstituteIndianapolis IN. 46260View Details -
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Summit HealthBend OR. 97701View Details -
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Toronto General HospitalToronto M5G 2C4View Details -
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Vancouver General HospitalVancouver BC. V5Z 1M9View Details -
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Centre d'investigation Clinique MauricieTrois-Rivières QC. G8T 7A1View Details -
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Dynamic Drug Advancement Ltd.Ajax ON. L1S 2J5View Details -
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Dr. Anil Dhar Medicine Professional CorporationWindsor N8X 5A6View Details -
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Centre d'Investigation Clinique Mauricie /ID# 277949Trois-Rivières QC. G8T 7A1View Details -
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Hannibal Regional Hospital /ID# 277984Hannibal MO. 63401View Details -
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Christie Clinic on University /ID# 277871Champaign IL. 61820View Details -
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Sec Clinical Research - East - Dothan - Graceland /ID# 278328Dothan AL. 36305View Details -
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Virginia Commonwealth UniversityRichmond VA. 23219View Details -
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
QEII Health Sciences CentreHalifax NS. B3H 3A7View Details -
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
University of MichiganAnn Arbor MI. 48109View Details -
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Vanderbilt University Medical CenterNashville TN. 37204View Details